AURINIA PHARMACEUTICALS INC's ticker is AUPH and the CUSIP is 05156V102. A total of 171 filers reported holding AURINIA PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is 1.37 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $30,845,610 | -19.7% | 3,969,834 | 0.0% | 2.38% | -18.8% |
| Q2 2023 | $38,427,993 | -11.7% | 3,969,834 | 0.0% | 2.93% | -2.5% |
| Q1 2023 | $43,509,381 | +153.7% | 3,969,834 | 0.0% | 3.01% | +212.0% |
| Q4 2022 | $17,149,683 | -42.6% | 3,969,834 | 0.0% | 0.96% | -35.3% |
| Q3 2022 | $29,853,000 | -25.2% | 3,969,834 | 0.0% | 1.49% | -27.3% |
| Q2 2022 | $39,897,000 | -18.8% | 3,969,834 | 0.0% | 2.05% | +44.3% |
| Q1 2022 | $49,146,000 | -30.0% | 3,969,834 | +29.3% | 1.42% | +0.1% |
| Q4 2021 | $70,207,000 | -38.7% | 3,069,834 | -40.7% | 1.42% | +4.3% |
| Q3 2021 | $114,471,000 | +70.8% | 5,172,683 | 0.0% | 1.36% | +55.8% |
| Q2 2021 | $67,038,000 | -0.2% | 5,172,683 | 0.0% | 0.87% | -42.1% |
| Q1 2021 | $67,193,000 | -6.1% | 5,172,683 | 0.0% | 1.51% | -20.2% |
| Q4 2020 | $71,538,000 | -6.1% | 5,172,683 | 0.0% | 1.89% | -41.4% |
| Q3 2020 | $76,194,000 | -9.4% | 5,172,683 | 0.0% | 3.23% | -4.5% |
| Q2 2020 | $84,056,000 | +12.0% | 5,172,683 | 0.0% | 3.38% | -13.8% |
| Q1 2020 | $75,056,000 | -28.4% | 5,172,683 | 0.0% | 3.92% | -20.9% |
| Q4 2019 | $104,799,000 | +279.4% | 5,172,683 | 0.0% | 4.96% | +116.7% |
| Q3 2019 | $27,622,000 | -18.8% | 5,172,683 | 0.0% | 2.29% | -4.1% |
| Q2 2019 | $34,036,000 | +1.2% | 5,172,683 | 0.0% | 2.38% | +36.5% |
| Q1 2019 | $33,622,000 | +2.5% | 5,172,683 | +7.6% | 1.75% | +34.3% |
| Q4 2018 | $32,794,000 | +2.7% | 4,808,483 | 0.0% | 1.30% | -5.7% |
| Q3 2018 | $31,928,000 | +17.9% | 4,808,483 | 0.0% | 1.38% | +8.7% |
| Q2 2018 | $27,072,000 | +8.5% | 4,808,483 | 0.0% | 1.27% | +14.2% |
| Q1 2018 | $24,956,000 | +14.6% | 4,808,483 | 0.0% | 1.11% | +23.1% |
| Q4 2017 | $21,782,000 | -27.8% | 4,808,483 | 0.0% | 0.90% | -14.6% |
| Q3 2017 | $30,149,000 | +2.3% | 4,808,483 | 0.0% | 1.06% | -1.5% |
| Q2 2017 | $29,476,000 | -16.5% | 4,808,483 | 0.0% | 1.07% | -12.7% |
| Q1 2017 | $35,294,000 | +313.2% | 4,808,483 | +18.2% | 1.23% | +261.2% |
| Q4 2016 | $8,542,000 | +11.4% | 4,067,743 | +59.7% | 0.34% | -1.2% |
| Q3 2016 | $7,666,000 | +8.7% | 2,546,843 | 0.0% | 0.34% | -6.0% |
| Q2 2016 | $7,055,000 | -4.8% | 2,546,843 | 0.0% | 0.37% | -25.6% |
| Q1 2016 | $7,411,000 | +17.8% | 2,546,843 | 0.0% | 0.49% | +23.0% |
| Q4 2015 | $6,291,000 | -13.0% | 2,546,843 | 0.0% | 0.40% | -16.1% |
| Q3 2015 | $7,233,000 | -6.0% | 2,546,843 | 0.0% | 0.48% | +18.7% |
| Q2 2015 | $7,691,000 | -30.7% | 2,546,843 | 0.0% | 0.40% | -19.9% |
| Q1 2015 | $11,104,000 | +19.8% | 2,546,843 | 0.0% | 0.50% | +11.6% |
| Q4 2014 | $9,271,000 | +13.8% | 2,546,843 | 0.0% | 0.45% | +8.7% |
| Q3 2014 | $8,150,000 | – | 2,546,843 | – | 0.41% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blackcrane Capital, LLC | 503,248 | $6,535,000 | 10.30% |
| Prosight Management, LP | 360,834 | $4,685,000 | 3.84% |
| Healthcare Value Capital, LLC | 100,000 | $1,299,000 | 2.89% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 1,748,208 | $22,700,000 | 2.32% |
| DG Capital Management, LLC | 591,154 | $7,676,000 | 1.83% |
| NEA Management Company, LLC | 5,172,683 | $67,193,000 | 1.51% |
| Altium Capital Management LP | 408,908 | $5,310,000 | 1.47% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 170,316 | $2,212,000 | 1.17% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 298,500 | $3,875,000 | 1.02% |
| KNOTT DAVID M | 154,840 | $2,011,000 | 0.86% |